These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38468221)

  • 1. Distributive randomization: a pragmatic fractional factorial design to screen or evaluate multiple simultaneous interventions in a clinical trial.
    Haviari S; Mentré F
    BMC Med Res Methodol; 2024 Mar; 24(1):64. PubMed ID: 38468221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions in the 2×2×2 factorial randomised clinical STEPCARE trial and the potential effects on conclusions: a protocol for a simulation study.
    Olsen MH; Jensen AKG; Dankiewicz J; Skrifvars MB; Reinikainen M; Tiainen M; Saxena M; Aneman A; Gluud C; Ullén S; Nielsen N; Jakobsen JC
    Trials; 2022 Oct; 23(1):889. PubMed ID: 36273179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, analysis and presentation of factorial randomised controlled trials.
    Montgomery AA; Peters TJ; Little P
    BMC Med Res Methodol; 2003 Nov; 3():26. PubMed ID: 14633287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulation and minimization: technical advances for factorial experiments designed to optimize clinical interventions.
    Kuhn J; Sheldrick RC; Broder-Fingert S; Chu A; Fortuna L; Jordan M; Rubin D; Feinberg E
    BMC Med Res Methodol; 2019 Dec; 19(1):239. PubMed ID: 31842765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial designs for evaluating combination HIV prevention approaches.
    Chen YQ; Peng L; Wang Y; Appelmans E; Dasgupta S; Fleming TR
    HIV Res Clin Pract; 2020; 21(2-3):72-82. PubMed ID: 32698705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When should factorial designs be used for late-phase randomised controlled trials?
    White IR; Szubert AJ; Choodari-Oskooei B; Walker AS; Parmar MK
    Clin Trials; 2024 Apr; 21(2):162-170. PubMed ID: 37904490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-factorial analyses of two-by-two factorial trial designs.
    Korn EL; Freidlin B
    Clin Trials; 2016 Dec; 13(6):651-659. PubMed ID: 27439306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample size requirements for separating out the effects of combination treatments: randomised controlled trials of combination therapy vs. standard treatment compared to factorial designs for patients with tuberculous meningitis.
    Wolbers M; Heemskerk D; Chau TT; Yen NT; Caws M; Farrar J; Day J
    Trials; 2011 Feb; 12():26. PubMed ID: 21288326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving pragmatic clinical trial design using real-world data.
    Shortreed SM; Rutter CM; Cook AJ; Simon GE
    Clin Trials; 2019 Jun; 16(3):273-282. PubMed ID: 30866672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dynamic block randomization and minimization in randomized trials: a simulation study.
    Xiao L; Lavori PW; Wilson SR; Ma J
    Clin Trials; 2011 Feb; 8(1):59-69. PubMed ID: 21335590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and analysis of a 2-year parallel follow-up of repeated ivermectin mass drug administrations for control of malaria: Small sample considerations for cluster-randomized trials with count data.
    Jackson CL; Colborn K; Gao D; Rao S; Slater HC; Parikh S; Foy BD; Kittelson J
    Clin Trials; 2021 Oct; 18(5):582-593. PubMed ID: 34218684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cluster over individual randomization: are study design choices appropriately justified? Review of a random sample of trials.
    Taljaard M; Goldstein CE; Giraudeau B; Nicholls SG; Carroll K; Hey SP; Brehaut JC; Jairath V; London AJ; Eldridge SM; Grimshaw JM; Fergusson DA; Weijer C
    Clin Trials; 2020 Jun; 17(3):253-263. PubMed ID: 32367741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factorial designs: an overview with applications to orthodontic clinical trials.
    Pandis N; Walsh T; Polychronopoulou A; Katsaros C; Eliades T
    Eur J Orthod; 2014 Jun; 36(3):314-20. PubMed ID: 23885023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An examination of effect estimation in factorial and standardly-tailored designs.
    Allore HG; Murphy TE
    Clin Trials; 2008; 5(2):121-30. PubMed ID: 18375650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.